Inhibition of steroid 5 alpha-reductase activity by aliphatic fatty acids. Candidates for chemoprevention of prostate cancer.
Niederprüm
H J
HJ
Institute of Immunology, Witten/Herdecke University, Germany.
Schweikert
H U
HU
Thüroff
J W
JW
Zänker
K S
KS
D058891:5-alpha Reductase Inhibitors; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology*; D005347:Fibroblasts / Q000201:enzymology; D006801:Humans; D007700:Kinetics; D007850:Lauric Acids / Q000494:pharmacology; D008297:Male; D011467:Prostate / Q000201:enzymology*; D011471:Prostatic Neoplasms / Q000517:prevention & control*; D013329:Structure-Activity Relationship
D058891:5-alpha Reductase Inhibitors; D016588:Anticarcinogenic Agents; D004791:Enzyme Inhibitors; D005230:Fatty Acids, Nonesterified; D007850:Lauric Acids; C030358:lauric acid